Baculovirus expression of functional P210 BCR-ABL oncogene product

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The P210 BCR-ABL oncoprotein is associated with chronic myelogenous leukemia.
• Understanding its biochemical properties is vital for therapeutic development.

Purpose of the Study:

• To produce functional P210 BCR-ABL protein using the baculovirus expression system.
• To characterize the enzymatic activity and biophysical properties of the recombinant protein.

Main Methods:

• Baculovirus expression system for P210 BCR-ABL production.
• Removal of GC-rich 5' non-coding sequences for high-level expression.
• Enzymatic assays (tyrosine kinase activity, Km for ATP) and autophosphorylation studies.
• Biophysical characterization using gel filtration chromatography.
• Purification strategies including ion exchange, gel filtration, detergent extraction, and immunoaffinity chromatography.

Main Results:

• High-level expression of P210 BCR-ABL was achieved after modifying the 5' non-coding sequences.
• The synthesized protein exhibited indistinguishable active tyrosine protein kinase activity compared to human-derived P210 BCR-ABL.
• The protein utilized angiotensin II as a phosphate acceptor with a Km for ATP of approximately 1.5 microM.
• In vitro and in vivo autophosphorylation was observed.
• Gel filtration indicated the protein exists as a high molecular weight complex (~800 kD).
• Purification yielded soluble, active P210 BCR-ABL, with improved methods offering higher purity and yield.

Conclusions:

• The baculovirus system successfully produced intact, soluble, and enzymatically active P210 BCR-ABL.
• This recombinant protein is a valuable tool for detailed biochemical and biophysical studies of the ABL oncogene family.
• The availability of this protein facilitates research into the mechanisms of chronic myelogenous leukemia.